Concepedia

Dov Terkieltaub

DT

5

Publications

337

Citations

5

H-Index

2000

Active since

Affiliations

Protalix BioTherapeutics (Israel)(Current)

Weizmann Institute of Science

Hadassah Academic College

Hebrew University of Jerusalem

Stanford University

Dov Terkieltaub is an author at Protalix BioTherapeutics (Israel) specializing in hepatology, vaccination, and immunotherapy.

Top concepts

Publications per year

2000–2006

5

Publications

5

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Rachel Eren, Dorit Landstein, Dov Terkieltaub et al. · Journal of Virology · 2006 · 101 citations · Full text

, , +22

Preclinical Evaluation of Two Human Anti-Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees

Rachel Eren, Ehud Ilan, Ofer Nussbaum et al. · Hepatology · 2000 · 83 citations · Full text

Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties

Eithan Galun, Rachel Eren, Rifaat Safadi et al. · Hepatology · 2002 · 81 citations

, , +17

Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity

Eithan Galun, Norah A. Terrault, Rachel Eren et al. · Journal of Hepatology · 2006 · 40 citations · Full text

Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the Trimera mouse

Wulf O. Böcher, Eithan Galun, Hadar Marcus et al. · Hepatology · 2000 · 32 citations · Full text

Rows per page

1–5 of 5